Cefdinir
Visa No.: 893110084424
Product: Ceftanir
API: Cefdinir
Product Category: Antibiotics
Version approved leaflet: 1408e/QLD-ĐK_14/01/2025
INDICATIONS
Treatment of infections caused by susceptible bacteria:
- Community-acquired pneumonia.
- Acute exacerbations of chronic bronchitis.
- Acute sinusitis.
- Pharyngitis and tonsillitis.
- Skin and skin structure infections.
DOSAGE AND ADMINISTRATION
Adults and children over 12 years of age:
- Community-acquired pneumonia: 300 mg twice daily for 10 days
- Acute exacerbations of chronic bronchitis: 300 mg twice daily or 600 mg once daily for 10 days
- Acute sinusitis: 300 mg twice daily or 600 mg once daily for 10 days
- Pharyngitis and tonsillitis: 300 mg twice daily or 600 mg once daily for 5–10 days.
- Skin and skin structure infections: 300 mg twice daily for 10 days.
Patients with renal impairment: In adults with creatinine clearance < 30 ml/min, cefdinir should be administered at a dose of 300 mg/day.
Patients undergoing hemodialysis: For patients on hemodialysis, the recommended dose is 300 mg or 7 mg/kg administered at the end of each dialysis session (as cefdinir is removed from plasma by dialysis), followed by administration of the same dose every other day.
CONTRAINDICATIONS
Patients with allergy or hypersensitivity to cephalosporin antibiotics.
WARNINGS AND PRECAUTIONS
Prescription only medicine. Read the instructions before use. Consult a physician or pharmacist if needed. Keep out of reach of children
